These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32454853)

  • 1. Prognostic Value of Functional Assessment of Cancer Therapy-General (FACT-G) in Advanced Non-Small-Cell Lung Cancer Treated with Korean Medicine.
    Jeon H; Eo W; Shim B; Kim S; Lee S
    Evid Based Complement Alternat Med; 2020; 2020():2845401. PubMed ID: 32454853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
    Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
    Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship Between Health-Related Quality of Life and Survival in Metastatic Colorectal Cancer Patients Treated With Korean Medicine.
    Park S; Eo W; Lee S
    Integr Cancer Ther; 2018 Mar; 17(1):65-72. PubMed ID: 28024424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patients.
    Hu Q; Li B; Garfield D; Ren S; Li A; Chen X; Zhou C
    Thorac Cancer; 2012 May; 3(2):162-168. PubMed ID: 28920299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy.
    Urba S; Gatz J; Shen W; Hossain A; Winfree K; Koustenis A; Peterson P; Cohen EE
    Oral Oncol; 2012 Aug; 48(8):723-9. PubMed ID: 22414289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Nutritional Status Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer?
    Seo Y; Eo W; Kim S; Shim B; Lee S
    Nutr Cancer; 2019; 71(7):1108-1117. PubMed ID: 31007069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Ferritin-to-Hemoglobin Ratio in Patients with Advanced Non-Small-Cell Lung Cancer.
    Lee S; Jeon H; Shim B
    J Cancer; 2019; 10(7):1717-1725. PubMed ID: 31205527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
    Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
    Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
    Yao ZH; Liao WY; Ho CC; Chen KY; Shih JY; Chen JS; Lin ZZ; Lin CC; Chih-Hsin Yang J; Yu CJ
    Oncologist; 2017 Sep; 22(9):1075-1083. PubMed ID: 28507206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
    Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
    JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study.
    Song A; Eo W; Kim S; Shim B; Lee S
    BMC Complement Altern Med; 2018 Jun; 18(1):176. PubMed ID: 29879960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Host-related Biomarkers for Survival in Patients with Advanced Non-Small Cell Lung Cancer.
    Lee S; Eo W; Jeon H; Park S; Chae J
    J Cancer; 2017; 8(15):2974-2983. PubMed ID: 28928889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
    Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
    PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
    Park SJ; Lee CS; Chung SS
    Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating survival and clinical outcome in advanced non-small cell lung cancer with bone-only metastasis using molecular markers.
    Meng C; Wei J; Tian J; Ma J; Liu N; Yuan Z; Zhao L; Wang P
    J Bone Oncol; 2021 Dec; 31():100394. PubMed ID: 34703756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
    Fiteni F; Vernerey D; Bonnetain F; Vaylet F; Sennélart H; Trédaniel J; Moro-Sibilot D; Herman D; Laizé H; Masson P; Derollez M; Clément-Duchêne C; Milleron B; Morin F; Zalcman G; Quoix E; Westeel V
    Eur J Cancer; 2016 Jan; 52():120-8. PubMed ID: 26682871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics.
    Wang J; Liu Y; Mi X; Shao M; Liu L
    Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of 112 elderly patients with advanced non-small cell lung cancer.
    Ran F; Liu Q
    Pak J Med Sci; 2022; 38(6):1674-1679. PubMed ID: 35991233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.